◄ back to all posts
Financial data and stock pages provided by
Fintel.io
◄ back to all posts
EBS: Emergent Biosolutions, Inc. Stock
Written by | Jul 6, 2018SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 5,833.09 |
Enterprise Value ($M) | 6,224.02 |
Book Value ($M) | 1,251.50 |
Book Value / Share | 23.61 |
Price / Book | 4.57 |
NCAV ($M) | -406.00 |
NCAV / Share | -7.66 |
Price / NCAV | -14.37 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.03 |
Return on Assets (ROA) | 0.02 |
Return on Equity (ROE) | 0.05 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.30 |
Current Ratio | 3.20 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 958.80 |
Assets | 2,616.30 |
Liabilities | 1,364.80 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 114.10 |
Net Income | 54.50 |
Earnings Per Share Diluted | 1.04 |
Earnings Per Share Basic | 1.06 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 188.00 |
Cash from Investing | -96.90 |
Cash from Financing | -96.90 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 9.04 | -3.42 | |
13G/A | BlackRock Inc. | 13.20 | 3.96 | |
13G/A | Dimensional Fund Advisors Lp | 3.32 | -24.79 | |
13G/A | Broadfin Capital, LLC | 1.70 | ||
13G/A | Bank of New York Mellon Corp | 4.81 | 274.63 | |
13G/A | Loomis Sayles & Co L P | 2.20 | ||
13G/A | Scopia Capital Management Lp | 0.00 | ||
13G/A | Royce & Associates Lp | 0.37 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
Quarterly Report – 10-Q | ||
Quarterly Report – 10-Q | ||
Quarterly Report – 10-Q | ||
Annual Report – 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
93,159 | 500,900 | 18.60 | |
53,079 | 513,200 | 10.34 | |
64,687 | 474,000 | 13.65 | |
(click for more detail) |
|||
(click for list of largest short owners) |
Similar Companies | |
---|---|
BXLT – Baxalta Incorporated | CBM – Cambrex Corp. |
CTLT – Catalent Inc. | ELAN – Elanco Animal Health Inc |
FRX – Forest Laboratories Inc |
Financial data and stock pages provided by
Fintel.io
2018/07/06